BCM
JNJ icon

Bayesian Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bayesian Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$331K Buy
+1,354
New +$315K 0.4% 76
2025
Q3 		– Sell
-9,700
Closed -$1.48M – 675
2025
Q2 		$1.48M Buy
+9,700
New +$1.49M 0.23% 127
2024
Q2 		– Sell
-20,700
Closed -$3.27M – 920
2024
Q1 		$3.27M Buy
+20,700
New +$3.29M 0.31% 79
2023
Q4 		– Sell
-51,300
Closed -$7.99M – 892
2023
Q3 		$7.99M Buy
51,300
+33,680
+191% +$5.56M 0.91% 16
2023
Q2 		$2.92M Sell
17,620
-16,341
-48% -$2.64M 0.31% 70
2023
Q1 		$5.26M Buy
+33,961
New +$5.48M 0.65% 18
2022
Q4 		– Sell
-3,218
Closed -$526K – 903
2022
Q3 		$526K Sell
3,218
-1,475
-31% -$250K 0.11% 269
2022
Q2 		$833K Sell
4,693
-2,307
-33% -$411K 0.16% 195
2022
Q1 		$1.24M Buy
7,000
+5,564
+387% +$947K 0.19% 160
2021
Q4 		$246K Buy
+1,436
New +$235K 0.08% 281
2021
Q3 		– Sell
-11,767
Closed -$1.94M – 463
2021
Q2 		$1.94M Buy
+11,767
New +$1.95M 0.51% 42
2021
Q1 		– Sell
-32,100
Closed -$5.05M – 615
2020
Q4 		$5.05M Buy
+32,100
New +$4.74M 1.32% 8
2020
Q1 		– Sell
-2,419
Closed -$353K – 878
2019
Q4 		$353K Sell
2,419
-5,181
-68% -$703K 0.06% 385
2019
Q3 		$983K Buy
+7,600
New +$1M 0.19% 146
2019
Q1 		– Sell
-8,764
Closed -$1.13M – 663
2018
Q4 		$1.13M Sell
8,764
-18,436
-68% -$2.57M 0.23% 134
2018
Q3 		$3.76M Buy
+27,200
New +$3.61M 0.62% 28
2018
Q1 		– Sell
-18,800
Closed -$2.63M – 710
2017
Q4 		$2.63M Sell
18,800
-1,400
-7% -$195K 0.54% 29
2017
Q3 		$2.63M Buy
+20,200
New +$2.68M 0.63% 21
2017
Q2 		– Sell
-6,906
Closed -$860K – 518
2017
Q1 		$860K Buy
+6,906
New +$825K 0.41% 66

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bayesian Capital Management's JNJ Position: Q1 2026 in Review

Bayesian Capital Management opened a new position in Johnson & Johnson (JNJ) in Q1 2026: 1,354 shares worth $331K. The stake represents 0.4% of the portfolio and ranks #76 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in JNJ as recently as Q2 2025.

Bayesian Capital Management first reported a position in JNJ in Q1 2017 and has held it in 19 quarters since. The position peaked at $7.99M in Q3 2023. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bayesian Capital Management held 1,354 shares of Johnson & Johnson worth $331K as of Q1 2026.
  • Johnson & Johnson was a new Bayesian Capital Management position in Q1 2026.
  • Johnson & Johnson made up 0.4% of Bayesian Capital Management's portfolio in Q1 2026, its #76 holding.
  • Bayesian Capital Management first reported a position in Johnson & Johnson in Q1 2017 and has held it in 19 quarters since.
  • Bayesian Capital Management's Johnson & Johnson position peaked at $7.99M in Q3 2023.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.